tirzepatide surmount 5 surmount-1 weight loss nondiabetic non-diabetic obesity trial For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults Tirzepatide after intensive lifestyle intervention – Tirzepatide superior to Semaglutide- SURMOUNT-5

For individuals with type 2 diabetes, low blood sugar levels (hypoglycemia) can be a concern when GLP-1 agonists are used in combination with other glucose-lowering medications, such as sulfonylureas or insulin

Hydration Strategies for Flights Staying hydrated can help you avoid common GLP-1 side effects like diarrhea, nausea, and constipation while traveling

Create a post-op checklist that includes prescribed meds, compression wear, walking schedule, sitting cushion, scar care supplies, and follow-up appointments

A systematic review and meta-analysis of the hyperuricemia risk from certain metals

Keeping a simple injection diary or using a smartphone app can help patients track their rotation pattern, particularly important for those using multiple injectable medications